| Literature DB >> 35746352 |
Irfan Ullah Khan1, Nida Aslam1, Fatima M Anis1, Samiha Mirza1, Alanoud AlOwayed1, Reef M Aljuaid1, Razan M Bakr1.
Abstract
A fetal ultrasound (US) is a technique to examine a baby's maturity and development. US examinations have varying purposes throughout pregnancy. Consequently, in the second and third trimester, US tests are performed for the assessment of Amniotic Fluid Volume (AFV), a key indicator of fetal health. Disorders resulting from abnormal AFV levels, commonly referred to as oligohydramnios or polyhydramnios, may pose a serious threat to a mother's or child's health. This paper attempts to accumulate and compare the most recent advancements in Artificial Intelligence (AI)-based techniques for the diagnosis and classification of AFV levels. Additionally, we provide a thorough and highly inclusive breakdown of other relevant factors that may cause abnormal AFV levels, including, but not limited to, abnormalities in the placenta, kidneys, or central nervous system, as well as other contributors, such as preterm birth or twin-to-twin transfusion syndrome. Furthermore, we bring forth a concise overview of all the Machine Learning (ML) and Deep Learning (DL) techniques, along with the datasets supplied by various researchers. This study also provides a brief rundown of the challenges and opportunities encountered in this field, along with prospective research directions and promising angles to further explore.Entities:
Keywords: amniotic fluid (AF); artificial intelligence; deep learning; machine learning; oligohydramnios; polyhydramnios; ultrasound
Mesh:
Year: 2022 PMID: 35746352 PMCID: PMC9228529 DOI: 10.3390/s22124570
Source DB: PubMed Journal: Sensors (Basel) ISSN: 1424-8220 Impact factor: 3.847
Figure 1Taxonomy of AF detection using AI techniques.
Figure 2Methodology adopted for the systematic review.
Summary of amniotic fluid classification studies using AI techniques.
| Domain | Ref. | Year | Data Type | Dataset Size | Binary/ | Augmentation | Methods | MSE | Accuracy |
|---|---|---|---|---|---|---|---|---|---|
| ML | [ | 2021 | US Images | 95 | Multi | No | RF | 0.9052 | |
| [ | 2021 | US Images | 50 | Multi | No | RF, DT | 0.995 | ||
| DL | [ | 2021 | US Images | 4000 | Multi | No | HBU-LSTM | 0.5244 | |
| [ | 2018 | US Images | 26 | Binary | Yes | CNN | 0.95 | ||
| [ | 2020 | US Images | 50 | Multi | No | Fuzzy Technique | 0.925 |
Summary of AF segmentation studies using AI techniques.
| Domain | Ref. | Year | Data Type | Dataset Size | Binary/ | Augmentation | Methods | DSC | Accuracy |
|---|---|---|---|---|---|---|---|---|---|
| DL | [ | 2021 | US Images | 435 | Binary | Yes | U-net (CNN) | 0.877 | |
| [ | 2021 | US Images | 2380 | Multi | Yes | AF-net + Auxiliary Network | 0.8599 | ||
| [ | 2021 | US Images | 2393 | Binary, Multi | No | FCNN | 0.84 | ||
| [ | 2017 | US Videos | 601 | Multi | Yes | CNN, Encoder–Decoder Network | 0.93 | ||
| ML | [ | 2021 | US Images | 55 | Binary | No | RF, DT, NB, SVM, and KNN | RF—0.876 | |
| [ | 2019 | US Images | 50 | Multi | Yes | RF | 0.5553 | 0.8586 | |
| [ | 2013 | US Images | 19 | Binary | No | Bayesian Formulation | Overlap Measure—0.89 |
Summary of studies investigating abnormal amniotic fluid causes using AI techniques.
| Condition | Ref. | Type | Year | Data Type | Dataset Size | Domain | Methods | Performance Measure |
|---|---|---|---|---|---|---|---|---|
| Oligo | [ | Placenta | 2017 | US Images | 2893 | DL | CNN, Random Walker | DSC-0.73 |
| [ | Placenta | 2019 | MRI Images | 1110 | DL | CNN (U-net) | Acc-0.98 | |
| [ | Placenta | 2018 | US Images | 1200 | DL | CNN | DSC-0.81 | |
| [ | Placenta | 2020 | US Images (3D) | 1054 | DL | U-net | DSC-0.87 | |
| [ | Placenta | 2019 | US Images | 1364 | DL | CNN | DSC-0.92 | |
| [ | Placenta | 2021 | US Images | 321 (patients) | DL | CNN | Acc-0.81 | |
| [ | Placenta | 2021 | US Images | 6576 | DL | U-net | Acc-0.84 | |
| [ | Placenta | 2020 | US Images | 11,014 | DL | U-net | Sen-0.75 | |
| [ | Placenta | 2018 | US Images | 47 (patients) | DL | JLF + CNN | DSC-0.863 | |
| [ | Placenta | 2020 | US Volumes | 101 | DL | KPL, ImageNet | ODS-0.605 | |
| [ | Placenta | 2019 | MRI Images | 64 (patients) | ML | KNN | Acc-0.981 | |
| [ | Placenta | 2019 | Photographic Images | 1003 | DL | CNN (PlacentaNet) | Acc-0.9751 | |
| [ | Placenta | 2017 | US Images (3D) | 104 (patients) | DL | FCNN, RNN | DSC-0.882 | |
| [ | Placenta | 2019 | US Images (3D) | 127 | DL | CNN | DSC-0.8 | |
| [ | Kidney | 2019 | US Images | 4074 | DL | CNN (AlexNet) | Acc-0.9705 | |
| Poly | [ | Neuro | 2020 | MRI Images | 227 | DL | SVM + CNN (AlexNet, ResNet50) | Acc-0.886 |
| [ | Neuro | 2021 | US Images | 63 | DL | CNN | ||
| Both | [ | TTTS | 2019 | US Videos | 900 | DL | CNN | DSC-0.9191 |
| [ | TTTS | 2020 | Fetoscopic Videos | 138,780 | DL | CNN and LSTM | Precision-0.96 | |
| [ | TTTS | 2020 | Fetoscopic Videos | 2400 | DL | CNN | - | |
| [ | TTTS | 2020 | Fetoscopic Images | 30,000 | DL | CNN | Acc-0.87 | |
| [ | Preterm | 2021 | Clinical Data | 219,272 (patients) | DL | DI-VNN | Sen-0.494 | |
| [ | Preterm | 2019 | Clinical Data | 25,689 (patients) | DL | RNN | Sen-0.819 | |
| [ | Health | 2021 | US Images | 3159 (patients) | ML | RF | MSE-0.02161 | |
| [ | Health | 2019 | US Images | 7875 (patients) | ML | SVM, DBN | MAPE-0.0609 | |
| [ | Health | 2021 | US Images | 1334 | DL | CNN (MFP-U-net) | DSC-0.98 |
Figure 3Distribution of the studies based on the AI method type.
Figure 4AI techniques used.
Figure 5Data types used by various studies.
Figure 6Dataset type and size of various studies.
Limitations and solutions of amniotic fluid studies.
| Ref. | Limitations | Solutions |
|---|---|---|
| [ | Limited features to differentiate between actual AF and reflected waves. | Considering AF coordinates. |
| [ | As there is no accurate measuring number for echogenicity, only doctor’s insight applied in observing the gray texture in US images. | - |
| [ | Fetal weight ignored for results. | Present findings considering fetal weight. |
| [ | Not entirely automated—Images manually labeled. | Automize labelling of US images. |
| [ | Uncertain aspects, such as angle and direction of the transducer, are ignored. | Considering maternal position during Amniotic Fluid Volume (AFV) measurement. |
| [ | Errors in final finding due to secondary path in complementation procedure. | Distinction between both paths. |
| [ | Moderate accuracy. | More broad case with additional clinical data and adequate labels. |
| [ | Average accuracy. | - |
| [ | Clinical data and US images exhibit moderate accuracy. | Omics data analysis to provide understanding to patients and help with clinical management. |
| [ | Various measurements scattered. | First trimester screening tool combining different measures and characteristics. |
| [ | Manual refinement of models. | Automate procedure. |